Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$11.78 - $16.98 $1.06 Million - $1.52 Million
-89,612 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$12.22 - $19.57 $77,548 - $124,191
6,346 Added 7.62%
89,612 $1.26 Million
Q3 2021

Nov 15, 2021

SELL
$15.42 - $21.72 $255,910 - $360,465
-16,596 Reduced 16.62%
83,266 $1.56 Million
Q2 2021

Aug 16, 2021

SELL
$20.85 - $29.88 $508,281 - $728,414
-24,378 Reduced 19.62%
99,862 $2.08 Million
Q1 2021

May 12, 2021

BUY
$24.75 - $39.14 $1.2 Million - $1.9 Million
48,440 Added 63.91%
124,240 $3.51 Million
Q4 2020

Feb 16, 2021

SELL
$29.0 - $41.62 $761,714 - $1.09 Million
-26,266 Reduced 25.73%
75,800 $2.48 Million
Q3 2020

Nov 16, 2020

BUY
$16.3 - $30.64 $1.66 Million - $3.13 Million
102,066 New
102,066 $3.13 Million
Q1 2018

May 14, 2018

SELL
$14.5 - $23.4 $725,000 - $1.17 Million
-50,000 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$13.5 - $16.65 $675,000 - $832,499
50,000
50,000 $0

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $598M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.